BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 21824082)

  • 1. The humoral immune response induced by snake venom toxins.
    da Silva WD; Tambourgi DV
    Inflamm Allergy Drug Targets; 2011 Oct; 10(5):343-57. PubMed ID: 21824082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune response towards snake venoms.
    León G; Sánchez L; Hernández A; Villalta M; Herrera M; Segura A; Estrada R; Gutiérrez JM
    Inflamm Allergy Drug Targets; 2011 Oct; 10(5):381-98. PubMed ID: 21824081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Snake antivenom: Challenges and alternate approaches.
    Alangode A; Rajan K; Nair BG
    Biochem Pharmacol; 2020 Nov; 181():114135. PubMed ID: 32628928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the Utility of Recombinant Snake Venom Serine Protease Toxins as Immunogens for Generating Experimental Snakebite Antivenoms.
    Alomran N; Blundell P; Alsolaiss J; Crittenden E; Ainsworth S; Dawson CA; Edge RJ; Hall SR; Harrison RA; Wilkinson MC; Menzies SK; Casewell NR
    Toxins (Basel); 2022 Jun; 14(7):. PubMed ID: 35878181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation.
    Gutiérrez JM; León G; Lomonte B
    Clin Pharmacokinet; 2003; 42(8):721-41. PubMed ID: 12846594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral immune responses to venom and antivenom of patients bitten by Bothrops snakes.
    Morais V; Berasain P; Ifrán S; Carreira S; Tortorella MN; Negrín A; Massaldi H
    Toxicon; 2012 Feb; 59(2):315-9. PubMed ID: 22206812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of the immune modulating effects of enzymatic toxins from snake venoms.
    Burin SM; Menaldo DL; Sampaio SV; Frantz FG; Castro FA
    Int J Biol Macromol; 2018 Apr; 109():664-671. PubMed ID: 29274419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Snake venoms in science and clinical medicine. 2. Applied immunology in snake venom research.
    Theakston RD
    Trans R Soc Trop Med Hyg; 1989; 83(6):741-4. PubMed ID: 2617643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial: Novel Immunotherapies Against Envenomings by Snakes and Other Venomous Animals.
    Laustsen AH; Ainsworth S; Lomonte B; Kini RM; Chávez-Olórtegui C
    Front Immunol; 2020; 11():1004. PubMed ID: 32670269
    [No Abstract]   [Full Text] [Related]  

  • 10. Snake venoms and their toxins: an Australian perspective.
    Hodgson WC; Wickramaratna JC
    Toxicon; 2006 Dec; 48(7):931-40. PubMed ID: 16920171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG subclass distributions of anti-horse serum antibodies and natural venom-antibodies produced in response to antivenom injection or snake bite in humans.
    Ameno S; Ameno K; Fuke C; Kiryu T; Ijiri I
    Toxicon; 1990; 28(3):347-50. PubMed ID: 2343468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antivenoms for snakebite envenomings.
    Gutiérrez JM; León G; Lomonte B; Angulo Y
    Inflamm Allergy Drug Targets; 2011 Oct; 10(5):369-80. PubMed ID: 21745181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Envenoming and antivenom use in Australia.
    White J
    Toxicon; 1998 Nov; 36(11):1483-92. PubMed ID: 9792162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Snake envenomation and protective natural endogenous proteins: a mini review of the recent developments (1991-1997).
    Thwin MM; Gopalakrishnakone P
    Toxicon; 1998 Nov; 36(11):1471-82. PubMed ID: 9792161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of a new therapy to treat snake envenomation.
    Shahidi Bonjar L
    Drug Des Devel Ther; 2014; 8():819-25. PubMed ID: 24971000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of convergent procoagulant toxicity and differential antivenom efficacy in Australian elapid snake venoms.
    Zdenek CN; den Brouw BO; Dashevsky D; Gloria A; Youngman NJ; Watson E; Green P; Hay C; Dunstan N; Allen L; Fry BG
    Toxicol Lett; 2019 Nov; 316():171-182. PubMed ID: 31442586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of immunoturbidimetry to detect venom-antivenom binding using snake venoms.
    O'Leary MA; Maduwage K; Isbister GK
    J Pharmacol Toxicol Methods; 2013; 67(3):177-81. PubMed ID: 23416032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alarmins and inflammatory aspects related to snakebite envenomation.
    Zuliani JP
    Toxicon; 2023 Apr; 226():107088. PubMed ID: 36924999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Snake venomics and antivenomics: Proteomic tools in the design and control of antivenoms for the treatment of snakebite envenoming.
    Gutiérrez JM; Lomonte B; León G; Alape-Girón A; Flores-Díaz M; Sanz L; Angulo Y; Calvete JJ
    J Proteomics; 2009 Mar; 72(2):165-82. PubMed ID: 19344652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current treatment for venom-induced consumption coagulopathy resulting from snakebite.
    Maduwage K; Isbister GK
    PLoS Negl Trop Dis; 2014 Oct; 8(10):e3220. PubMed ID: 25340841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.